ARONTIER
ARONTIER is an artificial intelligence-driven drug discovery company.
ARONTIER
Industry:
Artificial Intelligence (AI) Machine Learning Pharmaceutical
Founded:
2017-11-01
Address:
Seocho, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.arontier.co
Status:
Active
Contact:
82-2-597-0365
Technology used in webpage:
Domain Not Resolving Euro Google Maps Mobile Non Scaleable Content CrUX Dataset CrUX Top 10m Next.js Material-UI Django CSRF Sejong Telecom
Similar Organizations
AccutarBio
AccutarBio employs artificial intelligence to revolutionize drug discovery.
Agility Pharmaceuticals
Agility is an artificial intelligence (AI) driven pharmaceutical company.
AILON
AILON is an artificial intelligence lab that develops drugs through collaboration with institutions and pharmaceutical companies.
ALFI
ALFI is an artificial intelligence advertising platform
AZothBio
AZothBio is an artificial intelligence-based drug delivery system platform and new drug candidate discovery service.
FKAIR
FKAIR is an artificial intelligence research company.
Current Employees Featured
Founder
Official Site Inspections
http://www.arontier.co
- Host name: ec2-3-35-252-226.ap-northeast-2.compute.amazonaws.com
- IP address: 3.35.252.226
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "ARONTIER"
Arontier – Artificial Intelligence in Precision Medicine
Up-To-Date News about Arontier which is an artificial intelligence-driven drug discovery start-up company using bioinformatics, pharmacogenomics for incurable and rare diseases. ... and rare …See details»
LEADERSHIP - Arontier
About Us MISSION HISTORY LEADERSHIP TAKE A NEW LEAP FORWARD WITH INNOVATION TECHNOLOGY R&D Junsu Ko CEO & Co-founder CEO & Co-founderHead …See details»
MISSION - Arontier
Arontier has been selected for various projects and collaborations, establishing itself as a prominent corporation in the field of AI-driven drug discovery. We’ve recently launched our own AI-based drug discovery service platform, further …See details»
Arontier Company Profile 2024: Valuation, Funding & Investors
Arontier General Information Description. Developer of artificial intelligence-driven drug discovery platform intended for incurable and rare diseases. The company's platform offers tools for drug …See details»
Arontier Co., Ltd. - GitHub
Arontier Co., Ltd. has 15 repositories available. Follow their code on GitHub. Skip to content. Navigation Menu Toggle navigation. Sign in arontier. ... This organization has no public members. You must be a member to see who’s a …See details»
ARONTIER - Crunchbase Company Profile & Funding
ARONTIER is an artificial intelligence-driven drug discovery company. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log In. …See details»
Sarah Johnson - CEO - ARONTIER | LinkedIn
In 2017 he found Arontier Co., Ltd. Ever since then he has been doing research in AI-based drug discovery and participating in various drug development projects.See details»
ARONTIER - Contacts, Employees, Board Members, Advisors
Organization. ARONTIER . Connect to CRM ... We're working on getting contact data for ARONTIER . Find more contact data in Search! Get started . Employee Profiles. Edit …See details»
Arontier - Products, Competitors, Financials, Employees, …
Arontier an artificial intelligence (AI) drug development company that offers physics principles and machine learning algorithms to develop antibodies, protein binders, peptidomimetics, and …See details»
HISTORY – Arontier
About Us MISSION HISTORY LEADERSHIP TAKE A NEW LEAP FORWARD WITH INNOVATION TECHNOLOGY 2024 2024.03 MOU with Dongkook pharmaceutical on 'AI …See details»
ARONTIER - Tech Stack, Apps, Patents & Trademarks - Crunchbase
ARONTIER is an artificial intelligence-driven drug discovery company.See details»
Arontier Asset Profile - Preqin
The company was founded by its CEO, Junsu Ko, and CSO, Insuk Sohn. In July 2024, Arontier raised KRW 5 billion in venture funding from new investors HLB Group's HLB Investment and …See details»
PARTNERS – Arontier
PARTNERS Arontier Partners Next-generation AI-based drug discovery technologies ARONTIER TEL: +82-2-597-0365 | FAX: +82-2-587-0365 | Email: [email protected] TEL: …See details»
Arontier Co., Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Literatures (Medical) associated with Arontier Co., Ltd. Cancers Prediction of Lymph Node Metastasis in T1 Colorectal Cancer Using Artificial Intelligence with Hematoxylin and Eosin …See details»
Heeyoung Ahn | IEEE Xplore Author Details
Affiliations: [Department of R&D Center, Arontier Co., Ltd, Seoul, Republic of Korea]. Heeyoung Ahn. Affiliation. Department of R&D Center, Arontier Co., Ltd, Seoul, Republic of Korea ... A …See details»
ARONTIER - Crunchbase
Organization. ARONTIER . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Similar Companies. ... FKAIR is an artificial intelligence research …See details»
TEAMS – ADVISORY BOARD – Arontier
ARONTIER TEL: +82-2-597-0365 | FAX: +82-2-587-0365 | Email: [email protected] ARONTIER TEL: +82-2-597-0365 FAX: +82-2-587-0365 Email: [email protected] …See details»
Insuk Sohn - CSO & Co-founder @ ARONTIER - Crunchbase
Primary Job Title CSO & Co-founder; Primary Organization . ARONTIER . Location Seoul, Seoul-t'ukpyolsi, South Korea; Regions Asia-Pacific (APAC) Gender Male; Insuk Sohn is the CSO & …See details»
Arontier Co., Ltd. (Arontier Co., Ltd.) - 药物管线_专利_临床试验_投 …
了解Arontier Co., Ltd. (Arontier Co., Ltd.)公司的药物管线，治疗领域，技术平台，以及它的2篇文献。See details»
Arontier Co., Ltd. (Arontier Co., Ltd.) - 药物管线_专利_临床试验_投 …
项与 Arontier Co., Ltd. 相关的文献（医药） Cancers Prediction of Lymph Node Metastasis in T1 Colorectal Cancer Using Artificial Intelligence with Hematoxylin and Eosin-Stained Whole …See details»